Arcus Biosciences

📍 Hayward, United States🗓 Founded 2015👥 617 employees💰 Last funded Feb 2023
Biotechnology🌐 arcusbio.com
Website LinkedIn
Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people with cancer live longer. Located in the San Francisco bay area, Arcus Biosciences offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants. Arcus has an ambitious undertaking and expects to become a force in the discovery, development and commercialization of novel combination therapies to treat cancer in areas of high unmet need. Our employees enjoy operating in an exceptionally dynamic and team-driven environment in which the “rule book” has not yet been written.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2017–2023 · investors recorded per year
201712019120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Arcus Biosciences?
Arcus Biosciences has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Arcus Biosciences last raise funding?
The most recent investment in Arcus Biosciences recorded on gritt.io was in February 2023.
When was Arcus Biosciences founded?
Arcus Biosciences was founded in 2015.
What industry is Arcus Biosciences in?
Arcus Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Arcus Biosciences based?
Arcus Biosciences is headquartered in Hayward, United States.